HELX

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change -0.47
Percentage change -1.66	%

Category	Global or ExUS Equities - Industry Sector	Asset Type	Equities (Stocks)	Tags	Global	Return% 1Y	-10.72%	Total Holdings	68	Perf Week	-0.34%
Sponsor	Franklin Templeton	ETF Type		Tags	equity	Return% 3Y	-4.32%	AUM	11.25M	Perf Month	6.76%
Fund Family		Bond Type		Tags	healthcare	Return% 5Y	-1.38%	NAV/sh		Perf Quarter	-0.12%
Index	-	Average Maturity		Tags	genomics	Return% 10Y		52W High	33.98 -18.62%	Perf Half Y	-11.17%
Index Weighting		Commodity Type		Tags	-	Return% SI		52W Low	23.74 16.47%	Perf YTD	-4.16%
Active/Passive		Quant Type		Tags	-	Flows% 1M	0.00%	Volatility	0.53% 0.72%	Perf Year	-12.91%
Dividend TTM	-	ESG Type		Tags	-	Flows% 3M	0.00%	ATR (14)	0.36	Perf 3Y	-16.72%
Dividend Ex-Date	Dec 30, 2021	Dividend Type		Sector/Theme		Flows% YTD	-12.01%	RSI (14)	57.02	Perf 5Y	-4.94%
Dividend Gr. 3/5Y	- -	Structure Type		Region		Flows% 1Y		Beta	1.03	Perf 10Y	-
Expense	0.50%	Growth/Value		SMA20	1.83%	Flows% 3Y		Rel Volume	0.31	Prev Close	28.12
Inverse/Leveraged		Market Cap		SMA50	4.59%	Flows% 5Y		Avg Volume	2.86K	Price	27.65
IPO	Feb 27, 2020	Option/Short	Yes / Yes	SMA200	-6.20%	Trades		Volume	894	Change	-1.66%

May-02-25 03:25AM	Aim To Keep Risk Modest And Quality High (Seeking Alpha)
Apr-30-25 04:35AM	3 Ways To Avoid The Eye Of The Equity Market Storm (Seeking Alpha)
Apr-23-25 05:45AM	Rewiring Global Trade For Resilience And Growth (Seeking Alpha)
Apr-20-25 11:28AM	IDNA: The Cutting Edge Of Medical Science Is A Risky Investment (Seeking Alpha)
Apr-18-25 01:40PM	Institutional, Retail Investors Shed $27B In U.S. Stocks In Early April Sell-Off (Seeking Alpha)
08:30AM	Loading…
Apr-04-25 08:30AM	How Will New Tariffs Impact Your Investment Portfolio In 2025? (Seeking Alpha) -5.44%
Apr-02-25 07:00AM	The Great Transformation: Riding The Wave Of Change (Seeking Alpha)
Apr-01-25 05:40AM	U.S. Consumers To Be Hit Hardest By Pharmaceutical Tariffs (Seeking Alpha)
Mar-28-25 06:05AM	Volatility Brings Changes To Market Leadership (Seeking Alpha)
Mar-20-25 04:32PM	How ESG Policies Can Keep The Healthcare Sector Fighting Fit (SeekingAlpha)
Jul-16-21 11:19AM	Blockchain will be hugely disruptive to the finance industry: Jenny Johnson (Yahoo Finance Video)
Jan-14-21 09:15AM	Franklin Adds To Thematic ETF Line (ETF.com)
Oct-05-20 08:00AM	Franklin Templeton Gives Matt Moberg Three New Funds To Run (Investor's Business Daily)

Franklin Genomic Advancements ETF seeks capital appreciation. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities of companies that are relevant to its investment theme of genomic advancements. The fund invests predominantly in common stock. Although it may invest across economic sectors, the fund concentrates its investments in health care related industries. It is non-diversified.

open in yahoo | open in marketwatch | open in google

Franklin Genomic Advancements ETF

Upgrade your FINVIZ experience